DK1395231T3 - Præparat til fjernelse af abnormt keratinmateriale - Google Patents

Præparat til fjernelse af abnormt keratinmateriale

Info

Publication number
DK1395231T3
DK1395231T3 DK02732724T DK02732724T DK1395231T3 DK 1395231 T3 DK1395231 T3 DK 1395231T3 DK 02732724 T DK02732724 T DK 02732724T DK 02732724 T DK02732724 T DK 02732724T DK 1395231 T3 DK1395231 T3 DK 1395231T3
Authority
DK
Denmark
Prior art keywords
removal
preparation
keratin material
abnormal keratin
abnormal
Prior art date
Application number
DK02732724T
Other languages
Danish (da)
English (en)
Inventor
Horst Ulbricht
Samuel Shuster
Rainer Pooth
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1395231T3 publication Critical patent/DK1395231T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02732724T 2001-05-30 2002-05-17 Præparat til fjernelse af abnormt keratinmateriale DK1395231T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126501A DE10126501A1 (de) 2001-05-30 2001-05-30 Zubereitung zur Entfernung von abnormen Keratinmaterial
PCT/EP2002/005469 WO2002098380A1 (de) 2001-05-30 2002-05-17 Zubereitung zur entfernung von abnormen keratinmaterial

Publications (1)

Publication Number Publication Date
DK1395231T3 true DK1395231T3 (da) 2005-09-12

Family

ID=7686754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02732724T DK1395231T3 (da) 2001-05-30 2002-05-17 Præparat til fjernelse af abnormt keratinmateriale

Country Status (11)

Country Link
US (2) US20020197291A1 (enExample)
EP (1) EP1395231B1 (enExample)
JP (1) JP4359140B2 (enExample)
AT (1) ATE296607T1 (enExample)
CA (1) CA2448829C (enExample)
DE (2) DE10126501A1 (enExample)
DK (1) DK1395231T3 (enExample)
ES (1) ES2242027T3 (enExample)
MX (1) MXPA03009984A (enExample)
PT (1) PT1395231E (enExample)
WO (1) WO2002098380A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10061801A1 (de) * 2000-01-03 2001-07-12 Karl Kraemer Zubereitungen zur atraumatischen Nagelentfernung
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
DE602004024526D1 (de) * 2003-04-24 2010-01-21 Oreal Kosmetisches peeling-verfahren unter verwendung von harnstoff
EP1680076B1 (de) * 2003-08-25 2008-07-02 BioEqual AG Pharmazeutische und kosmetische formulierungen zur behandlung der nägel
DE102006049586A1 (de) * 2006-10-22 2008-04-24 Rudy Susilo Nagellackenferner für kosmetische und medizinische Anwendungen
US8293174B2 (en) * 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
US20090191138A1 (en) * 2008-01-30 2009-07-30 Mediquest Therapeutics, Inc. Novel topical formulations for improving the appearance of nails
NL1035426C2 (nl) * 2008-05-15 2009-11-17 Atp Marketing & Promotion Ag Farmaceutische samenstellingen voor de behandeling van wratten.
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
KR101055963B1 (ko) * 2008-12-01 2011-08-11 (주)더페이스샵 각질 박리 촉진용 화장료 조성물
WO2012110430A1 (en) * 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
US8673279B2 (en) * 2011-08-31 2014-03-18 Avon Products, Inc. Cosmetic liquid extractor comprising nonionic polymers
US9770609B2 (en) 2015-04-01 2017-09-26 Neat Feat Products Limited Urea based skin treatment
CN116211725A (zh) * 2022-12-13 2023-06-06 无锡知妍生物科技有限公司 一种洗去类高浓度尿素去角质凝胶及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402935A (en) * 1981-04-16 1983-09-06 Del Laboratories, Inc. Moisturizing nail polish composition
DE3520098A1 (de) * 1985-06-05 1986-12-11 Bayer Ag, 5090 Leverkusen Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung
AU599064B2 (en) 1985-11-04 1990-07-12 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5098421A (en) * 1989-10-16 1992-03-24 Zook Gerald P Viscoelastic gel foot padding and medicating device
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5639740A (en) * 1995-03-10 1997-06-17 Crandall; Wilson Trafton Topical moisturizing composition and method
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5993790A (en) * 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US5919470A (en) * 1998-04-02 1999-07-06 Bradley Pharmaceuticals, Inc. Dermatological composition
DE10061801A1 (de) 2000-01-03 2001-07-12 Karl Kraemer Zubereitungen zur atraumatischen Nagelentfernung
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
DE10126501A1 (de) 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6753071B1 (en) * 2001-09-27 2004-06-22 Advanced Cardiovascular Systems, Inc. Rate-reducing membrane for release of an agent
US6495602B1 (en) * 2001-12-13 2002-12-17 Bradley Pharmaceuticals, Inc. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
US6673842B2 (en) 2002-03-20 2004-01-06 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis
US6743417B2 (en) 2002-04-22 2004-06-01 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis with urea and an antioxidant
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
EP1395231A1 (de) 2004-03-10
CA2448829C (en) 2010-04-20
CA2448829A1 (en) 2002-12-12
JP2004532268A (ja) 2004-10-21
US7476396B2 (en) 2009-01-13
PT1395231E (pt) 2005-08-31
US20020197291A1 (en) 2002-12-26
EP1395231B1 (de) 2005-06-01
MXPA03009984A (es) 2004-02-12
JP4359140B2 (ja) 2009-11-04
ES2242027T3 (es) 2005-11-01
WO2002098380A1 (de) 2002-12-12
DE10126501A1 (de) 2002-12-12
US20040146555A1 (en) 2004-07-29
DE50203283D1 (de) 2005-07-07
ATE296607T1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
DK1395231T3 (da) Præparat til fjernelse af abnormt keratinmateriale
BR0215405A (pt) Composições e processos de uso de collajolie
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
DK0915898T3 (da) Krystalform I af clarithromycin
BR9908280A (pt) Inibidores de enzimas de fosfolipase
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
IS2156B (is) Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
WO2004069138A3 (en) Pharmaceutical formulation
DE69938935D1 (de) Zyklische conotoxin-peptide
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
BR0211063A (pt) Sais de derivados anticonvulsivantes
WO2004085682A3 (de) Caspase inhibitoren, insbesondere von caspase-3, zur behandlung von influenza
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
DE60137069D1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
WO2002096870A3 (en) Sponge-derived terpenoids and methods of use
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
EE200300065A (et) Meetod peptiidsoolade valmistamiseks, nende peptiidsoolade kasutamine ning neid peptiidsooli sisaldavad farmatseutilised preparaadid
DE502004012272D1 (de) Kosmetisches oder therapeutisches kombinationspraparat